Boston Scientific Corporation BSX recently received the FDA 510(k) clearance for its LUX-Dx Insertable Cardiac Monitor (“ICM”) System. Notably, ICM is a new long-term diagnostic device which is ...
Medtronic plc MDT recently announced the receipt of the FDA approval and the CE Mark for its LINQ II insertable cardiac monitor (“ICM”) with remote programming. Notably, ICM is a new long-term ...
The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population DUBLIN, Sept. 20, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader ...
The University of Michigan Frankel Cardiovascular Center is one of the nation's first hospitals to use the Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM) System, the smallest implantable ...
MARLBOROUGH, Mass., June 29, 2020 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the LUX-Dx™ Insertable Cardiac Monitor (ICM) ...
Boston Scientific Corporation BSX recently received the FDA 510(k) clearance for its LUX-Dx Insertable Cardiac Monitor (“ICM”) System. Notably, ICM is a new long-term diagnostic device which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback